Karachi, Citi Pharma Limited informed Pakistan Stock Exchange that the resolution passed in annual general meeting of the company held on October 28, 2022 at Lahore.
“Resolved that the Annual Audited Accounts of the company for the year ended June 30, 2022 together with the Reports of the Independent Auditors, Chairman and Director’s review reports thereon be and are hereby approved and adopted.”
“Citi Pharma Limited incorporated as a private limited company in Pakistan on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The factory is located at 3km Head Balloki road, Kasur. It has a land of 47 acres and has more than 800,000 Sq. Feet covered area.
The total numbers of shares are 207,692,000. The Earnings per share is 32.36 in 2020 which was 6.18 in 2019. The Profit after Taxation is 145,635,000 in 2020 which was 27,804,000 in 2019.”